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Electron microscopya b s t r a c t
Cryptosporidium parasites are a major cause of diarrhoea that pose a particular threat to children in devel-
oping areas and immunocompromised individuals. Curative therapies and vaccines are lacking, mainly
due to lack of a long-term culturing system of this parasite. Here, we show that COLO-680N cells infected
with two different Cryptosporidium parvum strains produce sufficient infectious oocysts to infect subse-
quent cultures, showing a substantial fold increase in production, depending on the experiment, over the
most optimistic HCT-8 models. Oocyst identity was confirmed using a variety of microscopic- and
molecular-based methods. This culturing system will accelerate research on Cryptosporidium and the
development of anti-Cryptosporidium drugs.
 2017 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Cryptosporidiosis causes a significant number of deaths in chil-
dren and immunocompromised individuals (Kotloff et al., 2013). It
is caused by species of the genus Cryptosporidium, in humans typ-
ically by Cryptosporidium parvum and Cryptosporidium hominis. The
Cryptosporidium spp. belong to the phylum Apicomplexa and it has
recently been proposed for the species to be reclassified as a mem-
ber of the subclass of gregarine (Ryan et al., 2016). They are water-
borne pathogens, and cryptosporidiosis has commonly been
associated with disease in developing countries. However, more
recent molecular epidemiological studies suggested that the dis-
ease is also an increasing health concern in developed countries
and may have reached epidemic levels (Kotloff et al., 2013;
Checkley et al., 2015). Only one moderately effective drug (nitazox-
anide) is available for the treatment of cryptosporidiosis. More
effective drugs are urgently needed (Checkley et al., 2015).Cryptosporidium is a parasite that invades host cells, within the
boundaries of the host cell membrane, residing intracellularly yet
extra-cytoplasmic, sometimes referred to simply as epicellular
(Ryan et al., 2016). Cryptosporidium typically infects epithelial tis-
sues of the upper intestinal tract, accompanied by localised deteri-
oration of microvilli. In immunocompromised individuals, the
parasite can also be found in other epithelial tissues including most
of the upper stages of the digestive and respiratory tracts as well as
other unrelated organ systems (Sponseller et al., 2014). The
Cryptosporidium life cycle is complex and involves a number of in
tracellular/extracytoplasmic and extracellular stages, resulting in
oocysts that contain the infective sporozoites (Supplementary
Fig. S1).
A cell culture system that enables continuous Cryptosporidium
cultivation and systematic elucidation of the Cryptosporidium life
cycle, especially the endogenous phases, is missing. Previous
approaches have been hampered by problems including rapid
senescence of primary cell cultures, incomplete parasite life cycles,
and insufficient production of sporulated infective oocysts (Karanis
and Aldeyarbi, 2011; Checkley et al., 2015). The current methods
used to produce infective Cryptosporidium oocysts, aside from
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mals, typically neonatal cows or sheep and sometimes mice
(Vinayak et al., 2015). Due to a lack of cryopreservation methods,
oocysts cannot be stored and need to be freshly prepared on a con-
tinuous basis. A recent publication tackled the challenge of cell
culture-based oocyst production using a hollow fiber technology
that mimics the gut (Morada et al., 2016). However, specialised
equipment is needed and the required cell culture media supple-
ments are expensive. In addition, the system does not enable study
of the Cryptosporidium life cycle and biology in real time at a cellu-
lar level in the context of a host cell.
Here, we show that inoculation of COLO-680N cultures with C.
parvum produced sufficient amounts of infective oocysts to enable
sustainable propagation of the parasite in standard tissue culture
at a laboratory scale. We tested a panel of seven human cancer cell
lines (using methods described in Supplementary Data S1) for their
capacity to support C. parvum propagation including COLO-680N
(oesophageal squamous-cell carcinoma), DLD-1 (colon adenocarci-
noma), KYSE-30 (oesophageal squamous-cell carcinoma), HCT-15
(colorectal adenocarcinoma), SJSA-1 (osteosarcoma), MKN-1 (gas-
tric carcinoma), and the colon adenoma carcinoma cell line HCT-
8, which has most commonly been used for the investigation of
Cryptosporidium in cell culture (Hijjawi et al., 2001). However,
Cryptosporidium-infected HCT-8 cultures do not produce enough
infective oocysts to maintain infected cultures (Muller and
Hemphill, 2013), which also raises concerns about the suitability
of HCT-8 for the study of Cryptosporidium biology. The cell lines
were infected with the C. parvum strain Moredun (Girouard et al.,
2006) using a total input of 5  105 of excysted oocysts per 10
mL of medium (25 cm2 flask). After an incubation period of 2
weeks, COLO-680N cultures were the only ones that had produced
substantially more oocysts (approximately 40-fold higher) than
the number of input oocysts (Fig. 1A, Supplementary Table S1).
While HCT-8 cells died after a few days of infection, COLO-680N
cultures remained viable and produced oocysts for almost 8 weeks
without sub-culturing, requiring only weekly medium exchange
(Fig. 1B). As a result, total Cryptosporidium oocyst production in
the COLO-680N cell line (number of oocysts produced) exceeded
the HCT-8-mediated oocyst production (2.5  105 oocysts/mL of
culture medium) by 20 times (5  106) after 10 days of incubation
(Fig. 1C). At day 60, COLO-680N cells had produced an accumulated
number of 1.2  107 oocysts/mL of culture medium obtained from
weekly harvests. Given that the initial oocyst count was 1  105
oocysts/ml, this represents a 50-fold increase in oocyst numbers
at 10 days p.i. and a 120-fold increase by the end of the culture.
Also of note, oocysts derived from the supernatants of COLO-
680N cell cultures, but not from the supernatants of HCT-8 cell cul-
tures, enabled the infection of novel cell cultures (Supplementary
Fig. S2C). Infection of COLO-680N cells with cattle-derived C. par-
vum oocysts resulted in similar amounts of infective oocysts in
25 independent experiments. In addition, we performed three
rounds of infection using COLO-680N culture-derived oocysts
without noticing changes in oocyst production efficacy, showing
that COLO-680N cells are suited for the continuous long-term cul-
tivation of C. parvum oocysts. Continuous C. parvum infections of
COLO-680N cells were confirmed using PCR primers specific to C.
parvum DNA, which displayed the presence of parasite DNA in both
the cell monolayer (Fig. 1D), and media fractions of the two-
dimensional (2-D) cultures (Fig. 1E). Cryptosporidium-specific pri-
mers did not produce bands in non-infected COLO-680N cells
(Fig. 1D and E; Supplementary Fig. S3). The amplified DNA regions
were sequenced to confirm their identity. In addition, purified
COLO-680N-produced oocysts were visualised by scanning elec-
tron microscopy (Fig. 1F). To evaluate our results even further,
we repeated the infection experiments using freshly excysted
and purified sporozoites; the purity of the sporozoites (absenceof oocysts in the sample) was validated using bright-field micro-
scopy. Quantitative PCR (qPCR) has demonstrated the production
of 2.4  106 oocysts (from an initial inoculation of 1  106 sporo-
zoites, Fig. 1I), 9 days p.i., and fluorescence microscopy confirmed
the presence of newly produced oocysts in the medium (Fig. 2E).
The discrepancy in the numbers of oocysts produced (from the
other experiments) could be a result of the oocyst treatment/
purification, the detection method using qPCR (Shahiduzzaman
et al., 2009), or the presence of a high amount of host cell material
(debris and RNA) that could inhibit the reaction. The produced
oocysts were used in two rounds of infection. The first round of
infection was done in triplicates in 12  25 cm2 flasks format and
the presence of oocysts was assessed by standard PCR analysis
using Heat shock protein 70 (Hsp70)-specific primers (Supplemen-
tary Table S2). Then crudely purified oocysts were used to re-infect
fresh COLO-680N cells, and the production of fresh ones was fur-
ther evaluated (Supplementary Fig. S4).
The identity of the COLO-680N-produced C. parvum oocysts was
further confirmed using different specific staining methods. Crypt-
a-glo (WaterborneTM; an antibody that recognises the oocyst cell
wall), Vicia villosa lectin (VVL, Vector laboratories, UK); binds to
O-glycan mucin repeats on C. parvum sporozoites), a mucin-like
glycoprotein that contains a C-type lectin domain (CpClec; binds
to surface of the apical region and to dense granules of sporozoites
and merozoites (Bhalchandra et al., 2013)) and direct sporozoite
staining using propidium iodide and Sporo-glo (WaterborneTM)
resulted in virtually identical staining patterns in C. parvum-
infected COLO-680N cells, indicating the presence of oocysts and
other non-extracellular life stages of Cryptosporidium (Fig. 2A; Sup-
plementary Figs. S5–S7; Supplementary Movie S1). Crypt-a-glo
staining did not reveal any significant differences between COLO-
680N- and cattle-produced oocysts (Fig. 2B and C). Closer examina-
tion of the produced oocysts did, however, appear to demonstrate
two morphological populations, which has been observed in C. par-
vum cultures previously (Thompson et al., 2005) (Fig. 2D; Supple-
mentary Movie S1). The comparison of Crypt-a-glo staining of C.
parvum-infected COLO680N- with HCT-8 cells further confirmed
that C. parvum-infected COLO-680N cultures are characterised by
enhanced numbers of infected cells compared with C. parvum-
infected HCT-8 cultures (Fig. 1G; Supplementary Fig. S5). To finally
confirm the production of fresh oocysts, Crypt-a-glo stained
oocysts were excysted (Supplementary Fig. S2A) and used for the
infection of COLO-680N cultures. Then, cell cultures were washed
to remove remaining Crypt-a-glo stained oocysts. Upon harvesting,
neither the infected cultures nor the newly produced oocysts dis-
played Crypt-a-glo staining. However, oocysts were detected using
DAPI, indicating that indeed new oocysts were produced (Supple-
mentary Fig. S2). We also subsequently have been able to propa-
gate successfully the alternative C. parvum Iowa strain in COLO-
680N cells (Supplementary Fig. S7).
In addition, we have attempted to resolve the issue of lacking of
a cryopreservation system that enables the long-term storage of
infective Cryptosporidium parasites. Here, C. parvum strain
Moredun-infected COLO-680N cells were cryopreserved, stored
for 2 weeks at 80 C, and resuscitated by standard protocols used
for cell cultures. Three days after resuscitation, the cultures started
to produce oocysts similar to freshly infected COLO-680N cultures
(Fig. 1H). This demonstrates that C. parvum-infected COLO-680N
can be cryo-conserved, providing the first known long-term stor-
age system for Cryptosporidium.
Next, we compared C. parvum- and non-infected cell cultures by
a MALDI-MS-based fingerprinting approach. Principal Component
Analysis (PCA) of the pre-processed data, as described in Supple-
mentary Data S1 and in more detail in Povey et al. (2014), resulted
in separate groupings of the COLO-680N, but not the HCT-8 sam-
ples (Supplementary Fig. S8A). We found substantial alterations
Fig. 1. Cell culture-based production of Cryptosporidium parvum oocysts (A) A bar chart representing the average C. parvum oocyst production (mean ± S.D. from three
independent experiments) in the investigated cell lines after initial infection with 1  105 excysted oocysts. Final oocyst counts are representative of total content recovered
after 14 days of incubation, regardless of host cell viability. Oocysts were recovered from cell culture media via saturated salt-column chromatography and counted via
haemocytometer. Initial experiments, infecting excysted oocysts, returned a near 40-fold return in oocysts by COLO-680N cultures, compared with only a two-fold return by
HCT-8 cells. (B) Bar chart of the time span during which oocysts were produced by COLO-680N and HCT-8 cultures after a single initial inoculation, representing the time from
when the first oocysts were detected in the harvest media until the last time an oocyst was detected (mean ± S.D. from three independent experiments). (C) Cryptosporidium
parvum oocyst production in COLO-680N and HCT-8 cancer cells over a 10 day period after an inoculation with 1  105 excysted oocysts, measured through daily sampling
via the same means as (A) (mean ± S.D. from three independent experiments). (D) PCR amplification of C. parvum 18S RNA (Cp18S, 580 bp, primers CF/CR) and heat shock
protein 70 (Hsp70) (CpHsp70, 462 bp, primers Hsp70F4/Hsp70R4) DNA fragments from C. parvum-infected COLO-608N cells. A Homo sapiens 18S DNA fragment (Hs18S, 418
bp, primers Hs18S1F/Hs18S1R) demonstrates abundance of host cell DNA in the sample. DNA extraction was performed at days 1, 2, 3, 4, 5, 6, 9 and 12 p.i., from DNA
extracted from cells removed from culture flasks via trypsin and washed multiple times at low speed (300 g) to remove extracellular stages. Cattle-derived C. parvum oocysts
(C. parvum) and uninfected COLO-680N cells (COLO-680N) served as controls. M1 is the 1 kb DNA ladder from Promega (UK). M2 is the 100 bp DNA ladder from Promega. (E)
PCR amplification of C. parvum 18S RNA (Cp18S, 580 bp, primers CF/CR) and Hsp70 (CpHsp70, 462 bp, primers Hsp70F4/Hsp70R4) DNA fragments from samples derived from
the supernatants of C. parvum-infected COLO-608N cells via percoll gradient after excystation. Input oocysts were removed by two washing steps with PBS (W1 and W2) 6 h
p.i., leaving no detectable C. parvum DNA in suspension. Time points and controls were the same as described in (D). (F) Scanning electron microscopy of COLO-680N
produced C. parvum oocysts. White arrows indicate Cryptosporidium oocysts. (G) Bar chart demonstrating the average number of C. parvum infections within cells in a 100
lm2 oil field at 1000x magnification at days 1 to 10 p.i., This data represents absolute infection numbers only as multiple infections per cell were possible (mean ± S.D. from
five independent experiments). Parasites were identified as the presence of co-localised propidium iodide and Sporo-glo within a host cell. (H) Oocyst production in C.
parvum-infected COLO-680N cell cultures after 2 weeks of cryopreservation and resuscitation (mean ± S.D. from three independent experiments). (I) Agarose gel analysis of a
quantitative PCR (qPCR) experiment with C. parvum-specific Hsp70LJ primers. Cattle-produced C. parvum oocysts were used as controls in two different DNA dilutions (1/10
and 1/100) of an initial concentration of 2  105 oocysts. qPCR was performed at day 9 (purified oocysts 1/100), where it amplified a corresponding band to estimate the
analogous concentration of oocysts. M is the 1 kb DNA ladder from Promega.
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COLO-680N cells 5 days after infection, but not between non-
infected and C. parvum-infected HCT-8 cells (Supplementary
Fig. S8B–E). These findings suggest C. parvum infection resulted
in a more noteworthy difference in COLO-680N cultures compared
with HCT-8, suggesting either a more successful infection (the
presence of an increased number of Cryptosporidium-originated
proteins) or a more pronounced effect on the host cell proteome
during infection.
Furthermore, we compared COLO-680N- and cattle-produced C.
parvum oocysts by a lipidomics approach and by atomic forcemicroscopy (AFM). The lipidomics characterisation was performed
using MALDI-TOF MS for the analysis of lipids within the range of
600 to 2,000 Da (Supplementary Fig. S9A–D). Graphical representa-
tion of the Principal Components (PC1 and PC2) from PCA (Povey
et al., 2014) showed groupings which could not substantially dif-
ferentiate between the oocysts of commercial (Bovine) or labora-
tory (COLO-680N) origins (Supplementary Fig. S9E and F). To
investigate the existence of oocysts at the highest magnification
possible, we employed AFM that has been used previously to elu-
cidate unique surface details at a level of resolution not visible
using any other imaging modalities in other parasites (e.g. Giardia
Fig. 2. Detection of Cryptosporidium parvum using different specific staining methods. All images were acquired 6 days p.i., after fixation and permeabilisation. (A) Visualisation
of C. parvum oocysts in infected COLO-680N cells. Cryptosporidium parvum oocysts were detected using Sporo-glo (Waterborne, USA), a fluorescein-labelled mouse
monoclonal antibody binding to Cryptosporidium (Aa), CpClec, that binds to the surface of the apical region and to dense granules of sporozoites and merozoites (Bhalchandra
et al., 2013) (Ab), and DAPI staining (Ac) that can be used to distinguish between host cell nuclei and parasites by morphological inference when coupled with differential
interference contrast (DIC) and other stains. (Ad) Merge of (Aa-c) conclusively showing that what is being observed is indeed C. parvum oocysts. (Ae) The corresponding DIC
microscopy image. Scale bar = 40 lm. VVL, Vicia villosa lectin. (B) Crypt-a-glo-stained cattle-produced oocyst. Scale bar = 5 lm. (C) Crypt-a-glo-stained COLO-680N-produced
oocysts. Scale bar = 5 lm. (D) COLO-680N-produced oocysts stained with Crypt-a-glo and DAPI. (Da). Crypt-a-glo, (Db) DAPI-merge). (Dc-e) Inset from Db showing an oocyst
at higher magnification, indicating DAPI staining of the four sporozoites. Scale bar = 5 lm. (E) COLO-680N-produced oocysts from a culture infected only with purified
sporozoites stained with Crypt-a-glo and DAPI. (Ea) Crypt-a-glo, (Eb) DAPI, (Ec) DIC. Scale bar = 10 lm.
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types of oocysts by AFM in C. parvum-infected COLO-680N cultures
(Supplementary Fig. S10C and D). We found a larger type of COLO-
680N-produced oocyst (Supplementary Fig. S10) that was indistin-
guishable from cattle-produced oocysts by force-distance curve-
based imaging (Supplementary Fig. S10A and B; Supplementary
Movie S2). These oocysts are likely to represent traditional, thick-
walled oocysts, since they are the larger and more rigid of the
structures and more closely resemble those produced by the cattle
(Thompson et al., 2005). We also identified a smaller type of oocyst
that upon casual observation appeared less structurally rigid and
may represent the thin-walled oocysts (Supplementary Fig. S10D).
In summary, we present a cell culture system that enables the
sustainable, continuous propagation of infective C. parvum oocysts
and the systematic investigation of Cryptosporidium oocysts. Previ-
ously, attempts to cultivate Cryptosporidium in cell culture wereaffected by a lack of production of sufficient amounts of infective
C. parvum oocysts (Tzipori and Widmer, 2008; Checkley et al.,
2015) or required sophisticated, expensive specialist equipment
and methodologies to support 3-D cultures that are not commonly
available to research laboratories (Morada et al., 2016). Moreover,
3-D cultures do not enable study of the C. parvum biology (Morada
et al., 2016). In contrast, COLO-680N cells enable C. parvum propa-
gation, the sustainable production of infective C. parvum oocysts,
and the investigation of C. parvum biology at a laboratory scale in
standard tissue cultures with commonly available equipment and
knowledge. In addition, these data demonstrate a long-term main-
tenance of the cell line and subsequently a prolonged production of
oocysts. The reasons behind this observation are unknown, but
previous studies on COLO-680N have suggested that the expres-
sion of high levels of fatty acid synthase might promote cell viabil-
ity (Orita et al., 2010). This could be beneficial to the parasite that
C.N. Miller et al. / International Journal for Parasitology 48 (2018) 197–201 201depends on host cell lipid synthesis, since it is unable to synthesize
fatty acids de novo (Zhu, 2004).
In conclusion, the discovery of COLO-680N as a cell culture plat-
form for the production of C. parvum will provide a step-change
with regard to research on Cryptosporidium as follows: (i) it is the
first easy-to-handle system that enables the long-term sustainable
production of infective oocysts at a laboratory scale and removes
the constant dependence on immunosuppressed animals for pro-
duction of Cryptosporidium oocysts along with all its ethical impli-
cations; (ii) C. parvum-infected cell cultures can be frozen and
stored. Prior to the establishment of the COLO-680N cultivation
system for C. parvum, oocysts had to be freshly acquired from ani-
mals and could not be stored over longer periods; (iii) our study
paves the way for establishment of compound-screening platforms
for the identification of anti-Cryptosporidium drugs and the
systematic elucidation of Cryptosporidium biology, including the
utilisation of a CRISPR transfection system for Cryptosporidium
(Vinayak et al., 2015). Hence, the COLO-680N-based platform for
C. parvum propagation will enable a much larger community to
work on Cryptosporidium and open unprecedented opportunities
to decipher Cryptosporidium biology and to develop anti-Cryp-
tosporidium therapies.
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